# shares traded lower on Tuesday, tracking a broader market downturn.

*business · news · 2026-04-07 · Benzinga*

## Key points

- Merck is acquiring Terns Pharmaceuticals for $53.00 per share in cash, with the offer expiring May 4, 2026.
- Merck's next financial update is scheduled for April 30, 2026, with an EPS estimate of -101 cents.
- Despite sector weakness, Merck has gained 44.67% over the last 12 months, nearing its 52-week high.
- JP Morgan recently raised Merck's price target to $135.00, reflecting continued analyst optimism.

**Companies:** Merck & Co.
**Countries:** United States

[Read the full story on Benzinga](https://www.benzinga.com/trading-ideas/movers/26/04/51686276/whats-going-on-with-merck-stock-tuesday)

---

Canonical: https://newsio.io/n/60f8b196-3e25-4b50-9d68-15f2fadd6e54/shares-traded-lower-on-tuesday-tracking-a-broader-market-downturn
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works